Erbitux 100mg Infusion
Marketer
Merck Ltd
Salt Composition
Cetuximab (100mg)
Overview Erbitux 100mg Infusion
Cetuximab 100mg intravenous infusion treats head and neck, colon, and rectal cancers. It targets cancer cells, enabling the immune system to eliminate them. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can have severe consequences. Discontinue only under your doctor's guidance. Common side effects include nausea, headache, vomiting, and skin rash; report any concerning symptoms. Seek immediate medical attention for sudden breathing difficulties, shortness of breath, fever, or chills. Regular blood tests monitor blood cell counts, heart, liver function, and electrolyte levels. Increased sun sensitivity necessitates sun protection. Inform your doctor of any pre-existing heart or kidney conditions, or medications (especially anti-infectives), before treatment. Many drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Primary Ingredients of Erbitux 100mg Infusion
No information provided. Please provide the text you wish me to rephrase.
Uses of Erbitux 100mg Infusion
Cancers affecting the head and neck, and colorectal cancer
Major Benefits of Erbitux 100mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Erbitux 100mg Infusion:
- Nausea
- Headache
- Vomiting
- Conjunctivitis
- Skin rash
- Diarrhea
- Infusion reaction
- Decreased magnesium level in blood
- Increased liver enzymes
How to use Erbitux 100mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Erbitux 100mg Infusion works:
Cetuximab 100mg infusion, a targeted therapy, utilizes a monoclonal antibody to attach to specific cancer cell receptors, thereby signaling these cells for elimination by the patient's own immune defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erbitux 100mg Infusion may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Cetuximab 100mg infusion may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the benefits against potential hazards prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The administration of 100mg Erbitux via infusion is likely unsafe while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Cetuximab 100mg intravenous infusion may impair driving ability due to potential adverse reactions.
KidneySAFE IF PRESCRIBED
Cetuximab 100mg infusion appears to pose minimal risk for individuals with impaired renal function. Preliminary findings indicate dose modification may be unnecessary for this patient population. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 100mg Erbitux infusions to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Erbitux 100mg Infusion :
Should you forget a scheduled Erbitux 100mg infusion, seek your physician's advice.
Facts to Know About Erbitux 100mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Monoclonal antibody EGFR (ErbB1/HER1) inhibitors |
3,018 People bought this recently